Banner of CND: United Nations Commission on Narcotic Drugs, policymaking body of the United Nations system with prime responsibility for drug-related matters.


The Commission holds annual sessions for the duration of one week in the first half of the year, as well as one-day reconvened sessions at the end of each year to consider administrative and budgetary matters. The Commission has a maximum number of eight working days for its session, pursuant to Economic and Social Council resolution 1991/39. In order to examine draft decisions, draft resolutions and specific technical issues, a Committee of the Whole is convened concurrently with the annual session of the Commission.

Intersessional meetings of the Commission are convened to finalize the provisional agenda of the Commission; to address organizational and substantive matters; and to provide continuous and effective policy guidance. The Commission also holds informal joint meetings of donor and recipient countries on the planning and formulation of projects, pursuant to its resolution 44/16.


  • 3-4 December: Reconvened 63rd session, Board-Room C, Vienna International Centre
  • 26 June, 2 p.m. Vienna Time (CEST), Special Event of the CND, Commemoration of the United Nations International Day against Drug Abuse and Illicit Trafficking and Launch of the 2020 World Drug Report followed by a Discussion on the impact of the Covid-19 pandemic on the world drug situation, virtual event
  • 12 June, 3 p.m. Vienna Time (CEST), Joint CND & CCPCJ Virtual Event  commemorating the twenty-fifth anniversary of the Fourth World Conference on Women and the adoption of the Being Declaration and Platform for Action (1995) and discussing how the COVID-19 pandemic is affecting women and girls
  • 2-6 March: 63rd session of the Commission on Narcotic Drugs, M-Building, Vienna International Centre
  • 28 February: 63rd session, pre-session consultations, Board-Room D, Vienna International Centre
  • 17 February: 1st intersessional meeting, Board-Room D, Vienna International Centre


Previous sessions of the Commission on Narcotic Drugs